Maelstrom | Crypto

"Maelstrom" in Crypto feed

  • Arthur Hayes dumps WLD days after Maelstrom’s AI IPO pitch
    Cointelegraph.com - 07:02 Jun 08, 2026
    Arthur Hayes dumps WLD days after Maelstrom’s AI IPO pitch Maelstrom’s Arthur Hayes has been on a selling spree recently, offloading positions in HYPE, ZEC, NEAR and now WLD. Maelstrom co-founder Arthur Hayes said he sold his Worldcoin (WLD) holdings just days after his venture capital firm described it as one of the cleanest proxies for the AI investment play.  “This chart is going in the wrong direction,” said Hayes on X on Saturday, showing a chart for the SpaceX pre-IPO perpetual futures contract, which had fallen sharply. “Dumped WLD. I’m out. See y’all at the clerb,” he added. Read more
  • Worldcoin is overlooked bet on AI IPO wave: Maelstrom
    Cointelegraph.com - 07:32 Jun 04, 2026
    Worldcoin is overlooked bet on AI IPO wave: Maelstrom Maelstrom predicts the WLD token will reach $5 by August, a gain of around 900% from current levels. Arthur Hayes’ investment firm Maelstrom said Worldcoin could surge to as high as $5 per token over the next few months, with WLD acting as a crypto proxy for the AI boom. “The AI mega IPOs are coming — and it appears the market has overlooked one of the cleanest proxies,” said Maelstrom researcher Lukas Ruppert on Wednesday.  The AI boom has been in full swing in the US. OpenAI confidentially filed its IPO prospectus with the SEC on May 22, targeting a public debut in September 2026, with the firm aiming to raise $60 billion with a potential valuation of up to $1 trillion.  Read more
  • Maelstrom, Animoca back Bio Protocol’s bid to unite AI, biotech, crypto
    Cointelegraph.com - 10:41 Sep 18, 2025
    Bio Protocol secured $6.9 million in funding from Maelstrom Fund, Animoca Brands and other investors to advance science using AI and crypto. Decentralized science (DeSci) platform Bio Protocol secured backing from investors including Maelstrom Fund and Animoca Brands to expand its artificial intelligence-native biotech research framework.  Bio Protocol announced Wednesday that it had raised $6.9 million in funding, reflecting growing interest in decentralized approaches to drug discovery that integrate AI, blockchain and community engagement.  Maelstrom founder Arthur Hayes described Bio Protocol as a potential “category-defining launchpad” for scientific research. “If it works, it’s not just a launchpad – it’s the birth of an AI-native research market,” he said. Read more
  • Bitcoin privacy tool Payjoin receives $100K grant from Maelstrom
    Cointelegraph.com - 10:45 May 20, 2025
    Maelstrom has awarded Bitcoin developer Ben Allen a $100,000 grant to improve Payjoin, a privacy-focused transaction method that could boost Bitcoin scalability. Bitcoin developer Ben Allen has received a $100,000 grant from investment firm Maelstrom to support the development of Payjoin, a privacy-focused tool aimed at improving Bitcoin’s scalability and privacy. According to a May 20 announcement shared with Cointelegraph, Maelstrom will finance Allen’s work on his Payjoin devkit alongside Dan Gould. The system allows Bitcoin (BTC) senders and receivers to use batched transactions, with positive implications for scalability and privacy. Payjoin was first proposed by Nicolas Dorier in 2019 in Bitcoin improvement proposal (BIP) 78. The core principle behind the system is that both senders and receivers may contribute inputs to a transaction. Read more